살유충제 시장 : 세계 예측(2026-2032년)

The Larvicides Market is projected to grow by USD 1.92 billion at a CAGR of 7.56% by 2032.

Larvicides are a critical component of integrated vector management, targeting mosquito, fly, and other disease-vector larvae before adult populations emerge. Their importance is increasing as public health authorities, municipalities, agricultural operators, and commercial pest control programs respond to persistent risks from dengue, malaria, chikungunya, Zika, West Nile virus, lymphatic filariasis, Japanese encephalitis, and nuisance biting insects. Unlike adulticides, larvicides support prevention-led vector control by interrupting breeding cycles in stagnant water, drainage systems, rice fields, wetlands, construction sites, containers, catch basins, and urban stormwater infrastructure. Demand is shaped by climate variability, urbanization, water storage practices, insecticide resistance, and the need for environmentally responsible pest management. The sector includes biological larvicides such as Bacillus thuringiensis israelensis and Lysinibacillus sphaericus, insect growth regulators, surface films, botanical formulations, and conventional chemical actives used under regulated application protocols. Relevant industry themes include mosquito larvicide, biological larvicide, vector control, public health pest management, integrated mosquito management, and larval source management. Across the value chain, the focus is shifting from broad reactive spraying to targeted, evidence-based programs that combine surveillance, habitat mapping, environmental management, community engagement, and precision larvicide application.

Transformative Shifts in the Larvicides Landscape

The larvicides landscape is being reshaped by intensifying vector-borne disease pressure, changing rainfall patterns, expanding peri-urban settlements, and stricter environmental scrutiny. Public health programs are prioritizing larval source management because controlling immature stages can reduce dependence on repeated adult mosquito interventions. This is especially relevant in dense urban settings where container-breeding Aedes species thrive and in rural or agricultural areas where irrigation, rice cultivation, and standing water create recurring breeding sites. Regulatory agencies and public health guidance increasingly emphasize integrated pest management, environmental assessment, appropriate product selection, and protection of non-target aquatic organisms. Biological larvicides and insect growth regulators are gaining strategic relevance because they can be integrated into resistance management programs and used in sensitive ecosystems when approved by local authorities. Another transformative shift is the movement toward operational precision: field teams increasingly rely on geospatial risk mapping, mobile reporting, remote sensing, and routine larval surveillance to determine where, when, and how to apply larvicides. Procurement expectations are also changing, with buyers seeking residual performance, ease of application, storage stability, safety documentation, compatibility with local regulations, and suitability for community-based vector control initiatives.

Cumulative Impact of Artificial Intelligence on Larvicide Programs

Artificial intelligence is strengthening larvicide programs by improving surveillance, prioritization, and operational efficiency. AI-enabled geospatial analytics can combine rainfall, temperature, land use, vegetation indices, drainage patterns, historical disease notifications, and field inspection data to identify probable breeding habitats and optimize larvicide deployment. Image recognition tools can support faster identification of larvae, breeding containers, and aquatic habitats from mobile devices, drone imagery, or laboratory workflows. Predictive models can help vector control teams anticipate seasonal mosquito abundance and allocate field resources before outbreaks accelerate. AI also supports resistance management by integrating entomological surveillance, product rotation histories, and treatment outcomes to flag areas where active ingredient performance may require review. In procurement and logistics, AI can improve inventory planning, route optimization, and application scheduling, reducing product waste and response delays. However, the cumulative impact of AI depends on high-quality local data, trained personnel, ethical use of health and location information, and validation against field outcomes. AI should therefore be treated as an enabling layer within integrated vector management rather than a substitute for entomological expertise, regulatory compliance, community engagement, and environmental assessment.

Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East & Africa

Asia-Pacific is a high-priority region for larvicides because tropical and subtropical climates, monsoon patterns, rapid urbanization, and water storage behaviors support the transmission ecology of dengue, malaria, Japanese encephalitis, chikungunya, and other vector-borne diseases. Countries across South and Southeast Asia emphasize community participation, container management, and larval source reduction, while biological larvicides and growth regulators are used in targeted public health programs where regulatory approvals and local conditions support deployment. North America has mature vector control infrastructure, with larvicides widely used by mosquito abatement districts, public health departments, and municipal programs to manage West Nile virus risk, nuisance mosquitoes, stormwater systems, catch basins, wetlands, and floodwater habitats. Latin America continues to face recurring dengue, Zika, chikungunya, and malaria pressures, making larvicides important in urban Aedes control, peri-domestic water storage management, and integrated campaigns that combine surveillance, public education, and environmental cleanup. Europe is shaped by climate-linked vector expansion, invasive Aedes species, wetland management requirements, and strict environmental regulation, creating demand for targeted, evidence-led larvicide use that minimizes non-target effects. The Middle East faces vector control needs linked to urban development, irrigation, water storage, construction activity, and population movement, with municipalities and health ministries using integrated pest management approaches in arid, irrigated, and coastal environments. Africa remains central to larvicide relevance because malaria, dengue emergence, urban drainage challenges, and rural water bodies create varied breeding habitats; larviciding is most effective where breeding sites are fixed, findable, and manageable, particularly in urban malaria control and localized community health interventions.

Group Insights Covering ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN countries experience substantial dengue and other Aedes-borne disease pressure, making larvicides a key tool in household container management, school and community campaigns, construction-site monitoring, and urban sanitation initiatives. Programs in this group increasingly combine larviciding with source reduction, digital surveillance, and public communication to improve compliance. GCC countries face distinctive vector control requirements driven by arid climates, desalinated and stored water systems, rapid infrastructure growth, landscaping irrigation, construction activity, and high population mobility; larvicide use is typically embedded in municipal pest management and environmental health programs that emphasize inspection, drainage maintenance, and regulated application. The European Union operates within stringent chemical and biocidal product governance, favoring risk assessment, environmental safety, product authorization, and integrated pest management principles; larvicides are applied selectively in wetlands, urban habitats, and invasive mosquito control programs where permitted. BRICS countries represent diverse larvicide dynamics, spanning tropical dengue control, malaria-endemic geographies, urban megacities, agricultural water systems, and large-scale public health operations, with emphasis on locally adapted formulations, surveillance capacity, and cost-effective implementation. G7 countries generally show advanced regulatory oversight, strong public health surveillance, and adoption of precision vector control practices, including larval habitat mapping and biological options in environmentally sensitive areas. NATO member states, while not a public health grouping, share operational interest in force health protection, base sanitation, and deployment-related vector control, where larvicides can support prevention in military installations, humanitarian missions, and overseas operations when aligned with host-country regulations.

Country Insights Across Major Larvicide Markets

The United States uses larvicides extensively through mosquito control districts, public health agencies, and local governments, particularly for West Nile virus prevention, floodwater mosquito management, catch basin treatment, and integrated mosquito management programs. Canada applies larvicides in provinces and municipalities to manage nuisance mosquitoes and vector risks, with strong attention to environmental approvals, wetlands stewardship, and local permitting. Mexico faces dengue, chikungunya, Zika, and malaria-related pressures in suitable ecological zones, supporting larvicide use alongside community clean-up, water container treatment, and surveillance. Brazil's large tropical territory and recurring arboviral disease burden make larval source management important in urban Aedes control, especially where household containers, water storage, and sanitation gaps sustain breeding. The United Kingdom's larvicide context is shaped by preparedness for invasive mosquito species, port and airport surveillance, climate adaptation, and localized nuisance management. Germany emphasizes regulated, environmentally responsible vector control, including targeted larviciding in floodplains and mosquito breeding areas where ecological assessments support intervention. France manages larvicide needs across mainland regions and overseas territories, with Aedes surveillance, dengue preparedness, and wetland-compatible control approaches being important. Russia's diverse climate creates localized mosquito management needs, including nuisance control and regional vector surveillance, with larviciding applied where breeding habitats are identifiable. Italy and Spain have elevated relevance due to invasive Aedes species, Mediterranean climate conditions, urban breeding sites, and public health preparedness for arboviral transmission. China integrates larvicides into broader vector control and public health sanitation initiatives, particularly in urban sanitation, dengue-prone southern areas, and environmental management. India has substantial larvicide relevance due to dengue, malaria, chikungunya, Japanese encephalitis, dense urbanization, water storage practices, and large public health programs that combine source reduction with targeted chemical and biological interventions. Japan maintains strong surveillance and environmental health systems, using larval control as part of preparedness for invasive mosquitoes and nuisance vector management. Australia applies larvicides in mosquito-prone coastal, wetland, and tropical regions, with programs addressing Ross River virus, Barmah Forest virus, dengue risk in northern areas, and environmentally sensitive habitats. South Korea's larvicide demand is linked to urban pest management, military and public health preparedness, climate-linked mosquito activity, and structured local government vector control operations.

Actionable Recommendations for Larvicide Industry Leaders

Industry leaders should align larvicide strategies with integrated vector management principles, prioritizing surveillance-led application rather than routine blanket treatment. Product development should emphasize environmental compatibility, resistance management, residual performance, ease of field deployment, and clear use instructions for diverse habitats such as catch basins, containers, wetlands, rice fields, and drainage channels. Stakeholders should strengthen partnerships with public health agencies, municipalities, agricultural authorities, and community organizations to ensure correct application, acceptance, and measurable outcomes. Investments in digital tools, including GIS mapping, mobile field reporting, AI-supported habitat prediction, and treatment verification, can improve operational transparency and resource allocation. Resistance monitoring should be incorporated into program design through active ingredient rotation, biological control integration, and routine evaluation of larval mortality. Regulatory readiness is essential: documentation on toxicity, non-target effects, residue behavior, worker safety, and label compliance should be robust and region-specific. Leaders should also prepare for climate-driven shifts in vector habitats by building flexible supply chains, training applicators, and supporting early-warning systems. Finally, communication should focus on public health value, safe use, and the role of larvicides within broader source reduction and sanitation programs.

Research Methodology for Evidence-Based Larvicide Analysis

A robust larvicides research methodology should combine secondary evidence review, primary expert validation, regulatory analysis, and field-level interpretation. Secondary research should draw from public health agencies, vector control guidelines, peer-reviewed entomology studies, environmental safety assessments, disease surveillance publications, climate and land-use datasets, and product registration frameworks. Primary research should include structured discussions with entomologists, vector control officers, public health planners, environmental regulators, procurement specialists, agricultural pest management professionals, and field applicators. Analytical evaluation should examine product types, active ingredient classes, use environments, application methods, resistance considerations, disease ecology, regional regulatory requirements, and operational constraints. Triangulation is essential to validate findings across scientific literature, official guidance, and practitioner experience. The methodology should avoid unsupported projections and instead emphasize verified trends, documented disease drivers, regulatory developments, technology adoption, and operational best practices. Quality control should include source credibility checks, consistency reviews, terminology standardization, and assessment of whether insights are applicable across different ecological and governance contexts. This evidence-led approach supports practical, Relevant executive analysis while maintaining scientific and commercial integrity.

Conclusion: Larvicides as a Prevention-First Vector Control Strategy

Larvicides are becoming increasingly important as public health systems and pest management programs shift toward prevention, precision, and environmental responsibility. By targeting vectors at the larval stage, they support integrated mosquito management, reduce reliance on adult mosquito control, and help address disease risks linked to urbanization, climate variability, water storage, and inadequate drainage. Biological larvicides, insect growth regulators, and carefully regulated chemical options each play distinct roles depending on habitat type, vector species, resistance profile, and environmental requirements. Regional and country dynamics show that larvicide adoption is shaped by disease burden, governance capacity, ecological conditions, regulatory oversight, and community participation. Artificial intelligence, geospatial analytics, and digital surveillance are improving the timing and targeting of interventions, but their value depends on strong field data and trained personnel. For industry leaders, the strongest opportunities lie in evidence-based product innovation, regulatory preparedness, integrated vector management partnerships, and transparent outcome measurement. The future of larvicides will be defined by targeted deployment, sustainability, and the ability to protect communities while preserving ecological balance.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Larvicides Market, by Product Type

• 7.1. Introduction
• 7.2. Biological Larvicides
  • 7.2.1. Bacterial Larvicides
  • 7.2.2. Fungal Larvicides
  • 7.2.3. Viral Larvicides
• 7.3. Physical Larvicides
• 7.4. Chemical Larvicides
  • 7.4.1. Organophosphates
  • 7.4.2. Carbamates
  • 7.4.3. Pyrethroids

8. Larvicides Market, by Formulation

• 8.1. Introduction
• 8.2. Granules
• 8.3. Liquid
  • 8.3.1. Emulsifiable
  • 8.3.2. Suspension
• 8.4. Pellets
• 8.5. Tablets

9. Larvicides Market, by Mode of Action

• 9.1. Introduction
• 9.2. Neurotoxic
• 9.3. Growth Regulation
• 9.4. Metabolic Disruption
• 9.5. Respiratory Blockage
• 9.6. Digestive System Disruption

10. Larvicides Market, by End User

• 10.1. Introduction
• 10.2. Agriculture
  • 10.2.1. Aquaculture
  • 10.2.2. Crop Protection
• 10.3. Commercial & Industrial
  • 10.3.1. Hospitality
  • 10.3.2. Real Estate Management
• 10.4. Public Health
  • 10.4.1. Government Agencies
  • 10.4.2. Private Mosquito Contractors
• 10.5. Residential
  • 10.5.1. Diy Kits
  • 10.5.2. Professional Services

11. Larvicides Market, by Distribution Channel

• 11.1. Introduction
• 11.2. Offline
• 11.3. Online
  • 11.3.1. E Commerce Platforms
  • 11.3.2. Manufacturer Websites

12. Larvicides Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Larvicides Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Larvicides Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. FPNV Positioning Matrix, 2025
• 15.3. Market Concentration Analysis, 2025
  • 15.3.1. Concentration Ratio (CR)
  • 15.3.2. Herfindahl Hirschman Index (HHI)
• 15.4. Recent Developments & Impact Analysis, 2025
• 15.5. Product Portfolio Analysis, 2025
• 15.6. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Ajay Biotech India Ltd.
• 16.2. AllPro Vector Group
• 16.3. BASF SE
• 16.4. Bayer AG
• 16.5. BABOLNA BIO Kft.
• 16.6. Cellgene Bio Science
• 16.7. Central Garden & Pet Company
• 16.8. Central Garden & Pet Company
• 16.9. Clarke Mosquito Control Products Inc.
• 16.10. Eagle Plant Protect Pvt. Ltd.
• 16.11. Eli Lilly and Company
• 16.12. FMC Corporation
• 16.13. Gowan Company
• 16.14. Insecticides India Limited
• 16.15. Isagro SpA
• 16.16. Kadant Inc.
• 16.17. Nufarm Limited
• 16.18. Proxima Bio-tech Pvt Ltd.
• 16.19. Redox Industries Limited
• 16.20. Russell IPM Ltd.
• 16.21. Sikko Industries Ltd.
• 16.22. Sumitomo Chemical Co.
• 16.23. UPL Ltd.